Ewa Aladowicz

Sutton Upon Derwent, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

High-Risk Rhabdomyosarcomas Feature a Convergent Cell State.

High-Risk Rhabdomyosarcomas Feature a Convergent Cell State.

Journal: Cancer research
Published: September 26, 2025

Pharmacological EZH2 inhibition combined with retinoic acid treatment promotes differentiation and apoptosis in rhabdomyosarcoma cells.

Pharmacological EZH2 inhibition combined with retinoic acid treatment promotes differentiation and apoptosis in rhabdomyosarcoma cells.

Journal: Clinical epigenetics
Published: July 03, 2023

Molecular Characterization of Circulating Tumor DNA in Pediatric Rhabdomyosarcoma: A Feasibility Study.

Molecular Characterization of Circulating Tumor DNA in Pediatric Rhabdomyosarcoma: A Feasibility Study.

Journal: JCO precision oncology
Published: October 20, 2022

FGF7-FGFR2 autocrine signaling increases growth and chemoresistance of fusion-positive rhabdomyosarcomas.

FGF7-FGFR2 autocrine signaling increases growth and chemoresistance of fusion-positive rhabdomyosarcomas.

Journal: Molecular oncology
Published: May 29, 2021

Role for the Histone Demethylase KDM4B in Rhabdomyosarcoma via CDK6 and CCNA2: Compensation by KDM4A and Apoptotic Response of Targeting Both KDM4B and KDM4A.

Role for the Histone Demethylase KDM4B in Rhabdomyosarcoma via CDK6 and CCNA2: Compensation by KDM4A and Apoptotic Response of Targeting Both KDM4B and KDM4A.

Journal: Cancers
Published: February 03, 2021

ShcD Binds DOCK4, Promotes Ameboid Motility and Metastasis Dissemination, Predicting Poor Prognosis in Melanoma.

ShcD Binds DOCK4, Promotes Ameboid Motility and Metastasis Dissemination, Predicting Poor Prognosis in Melanoma.

Journal: Cancers
Published: November 05, 2020

A Perspective on Polo-Like Kinase-1 Inhibition for the Treatment of Rhabdomyosarcomas.

A Perspective on Polo-Like Kinase-1 Inhibition for the Treatment of Rhabdomyosarcomas.

Journal: Frontiers in oncology
Published: August 21, 2019

Catalytic inhibition of KDM1A in Ewing sarcoma is insufficient as a therapeutic strategy.

Catalytic inhibition of KDM1A in Ewing sarcoma is insufficient as a therapeutic strategy.

Journal: Pediatric blood & cancer
Published: December 21, 2018

MicroRNA and gene co-expression networks characterize biological and clinical behavior of rhabdomyosarcomas.

MicroRNA and gene co-expression networks characterize biological and clinical behavior of rhabdomyosarcomas.

Journal: Cancer letters
Published: July 20, 2016

Investigating the metastatic niche in melanoma: a new therapeutic opportunity?

Investigating the metastatic niche in melanoma: a new therapeutic opportunity?

Journal: Future oncology (London, England)
Published: May 07, 2014

Molecular networks in melanoma invasion and metastasis.

Molecular networks in melanoma invasion and metastasis.

Journal: Future oncology (London, England)
Published: May 08, 2013
Showing 1-11 of 11

Last Updated: 09/26/2026